Kalobios Pharmaceuticals Inc (KBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KBIO | TEVA | RDY | BBIO | BHC |
| Company | Kalobios Pharmaceuticals Inc | Teva Pharmaceutical Industries ADR | Dr. Reddy's Laboratories Ltd ADR | Bridgebio Pharma Inc | Bausch Health Companies Inc |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NASDAQ | NYSE |
| Open | 1.6500 | 17.07 | 14.24 | 23.13 | 8.12 |
| High | 2.2000 | 17.13 | 14.30 | 23.65 | 8.19 |
| Low | 1.6200 | 16.87 | 14.12 | 22.47 | 7.96 |
| Last | 2.1900 | 17.12 | 14.20 | 23.42 | 7.97 |
| Change | +0.4630 | +0.04 | +0.21 | +0.18 | -0.21 |
| % Change | +26.81% | +0.23% | +1.50% | +0.77% | -2.57% |
| Volume | 29,900 | 7,441,573 | 1,342,964 | 2,088,400 | 1,647,480 |
| 20-Day Average Volume | 12,700 | 7,837,530 | 873,725 | 1,825,615 | 2,011,245 |
| Previous Close | 1.7270 | 17.08 | 13.99 | 23.24 | 8.18 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7043 | 17.54 | 14.68 | 24.44 | 8.81 |
| 20-Day Raw Stochastic | 98.57% | 30.70% | 15.60% | 29.06% | 0.53% |
| 20-Day Relative Strength | 60.40% | 45.32% | 37.74% | 44.12% | 44.01% |
| Weighted Alpha | -53.96 | +61.76 | -1.26 | -26.32 | +4.55 |
| Today's Opinion | N/A | 8% Buy | 56% Sell | 100% Sell | 40% Buy |
| Previous Opinion | N/A | 16% Buy | 56% Sell | 100% Sell | 48% Buy |
| Last Month's Opinion | N/A | 88% Buy | 24% Buy | 100% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +36.88% since 07/28/17 | +4.20% since 11/15/24 | +0.21% since 11/15/24 | -1.26% since 11/15/24 | -6.01% since 11/15/24 |
| Low | 1.5700 on 08/02/17 | 16.15 on 11/18/24 | 13.93 on 11/21/24 | 21.72 on 11/19/24 | 7.96 on 11/22/24 |
| High | 2.2000 on 08/04/17 | 17.17 on 11/21/24 | 14.40 on 11/20/24 | 24.25 on 11/18/24 | 8.51 on 11/18/24 |
| 1-Month | |||||
| %Chg | +12.31% since 07/03/17 | -6.86% since 10/22/24 | -10.85% since 10/22/24 | -6.09% since 10/22/24 | -1.73% since 10/22/24 |
| Low | 1.5000 on 07/11/17 | 16.15 on 11/18/24 | 13.93 on 11/21/24 | 21.72 on 11/19/24 | 7.96 on 11/22/24 |
| High | 2.2000 on 08/04/17 | 19.31 on 11/06/24 | 15.83 on 10/23/24 | 27.57 on 11/11/24 | 9.85 on 11/04/24 |
| 3-Month | |||||
| %Chg | -5.60% since 05/04/17 | -6.91% since 08/22/24 | -14.05% since 08/22/24 | -5.91% since 08/22/24 | +38.13% since 08/22/24 |
| Low | 1.5000 on 07/11/17 | 16.15 on 11/18/24 | 13.93 on 11/21/24 | 21.72 on 11/19/24 | 5.76 on 08/23/24 |
| High | 2.9500 on 05/17/17 | 19.31 on 11/06/24 | 16.77 on 08/28/24 | 32.06 on 09/05/24 | 9.85 on 11/04/24 |
| 6-Month | |||||
| %Chg | -28.20% since 02/03/17 | +1.42% since 05/22/24 | +1.88% since 05/22/24 | -19.99% since 05/22/24 | +25.12% since 05/22/24 |
| Low | 1.5000 on 07/11/17 | 15.62 on 07/01/24 | 13.61 on 05/31/24 | 21.62 on 06/24/24 | 3.96 on 07/24/24 |
| High | 3.2500 on 02/17/17 | 19.31 on 11/06/24 | 16.89 on 08/09/24 | 32.06 on 09/05/24 | 9.85 on 11/04/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 32,806 | 19,350,086 | 11,677,466 | 4,392,128 | 3,008,629 |
| Shares Outstanding, K | 14,980 | 1,132,909 | 834,701 | 188,990 | 367,803 |
| Annual Sales | 0 | 15,846,000,000 | 3,350,000,000 | 9,300,000 | 8,757,000,000 |
| Annual Net Income | -27,010,000 | -559,000,000 | 668,000,000 | -643,200,000 | -592,000,000 |
| Last Quarter Sales | N/A | 4,332,000,000 | 953,930,000 | 2,730,000 | 2,510,000,000 |
| Last Quarter Net Income | N/A | -437,000,000 | 149,380,000 | -162,040,000 | -85,000,000 |
| 60-Month Beta | 2.99 | 0.87 | 0.56 | 1.09 | 0.74 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.69 on 11/06/24 | 0.04 on 11/05/24 | -0.86 on 11/12/24 | 1.12 on 10/30/24 |
| Latest Earnings Date | 09/22/17 | 11/06/24 | 11/08/24 | 11/14/24 | 10/30/24 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | 0.404 on 07/30/24 | N/A | 1.000 on 11/10/10 |
| Next Ex-Dividends Date | N/A | 11/27/17 | 07/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.33 | 22.84 | 0.00 | 2.18 |